Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Fibrocell Science, Inc.

by

Fibrocell Science is a US public company that develops personalized autologous cell therapies for aesthetic, medical and scientific applications. It raised $9.3 million in a secondary public offering, as reported in the PharmSource Lead Sheet on December 14, 2017. Corporate Highlights Fibrocell Science was incorporated in Delaware in September 1992. Corporate Headquarters: Exton, PA As […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on Tear Film Innovations, Inc.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Tear Film Innovations is a private US company that develops medical devices for the treatment of evaporative dry eye […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Myovant Sciences, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Myovant Sciences Sciences is a US public company that focuses on treatments for women’s health diseases and other endocrine-related disorders. It plans to raise $300 […]

Learn more

Large Molecule API Sector Becomes Increasingly Crowded as Peregrine Changes Focus

by

Competition within the 2,000-5,000 L biomanufacturing segment is set to intensify as Peregrine Pharmaceuticals (Tustin, Calif., USA) announced its transition to a dedicated CDMO from an excess capacity player. The company announced the move during the company’s quarterly conference call. Subsequently, Mark Bamforth, currently Brammer Bio (Lexington, Mass., USA) CEO and president, was appointed to […]

Learn more

CDMO Acquisitions Build Strategic Supplier Base

by

By Jim Miller, President, PharmSource Reprinted with permission from Pharmaceutical Technology CDMO Acquisitions Build Strategic Supplier Base Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma. November 2017 This has been another big year for acquisitions in the contract development and manufacturing organization (CDMO) industry. In the first three quarters of 2017, there […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Protagonist Therapeutics, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Protagonist Therapeutics is a US public company that discovers and develops disulfide-rich peptides, alternatives to antibodies and new chemical entities to treat life-threatening diseases. It […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on AxioMed LLC

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. AxioMed is a US private company that focuses on products to address spinal function in patients with degenerative spine […]

Learn more

Follow the Money to Medical Devices & Diagnostics
Spotlight on Cambridge Medical Robotics Ltd.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Cambridge Medical Robotics is a private company based in the UK that develops next-generation robotic systems for minimal access […]

Learn more

Follow the Money to Bio/Pharmaceutical Opportunities
Spotlight on Fusion Pharmaceuticals, Inc.

by

Follow the Money to Bio/Pharmaceutical Opportunities highlights a newly funded bio/pharmaceutical company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Fusion Pharmaceuticals is a private company based in Canada that develops radiotherapeutics for the treatment of cancer. It raised $21 million in a venture capital […]

Learn more